Millions of people all over the world can now have a drug-free treatment option to reduce morning sickness, motion sickness and nausea related to both thanks to ReliefBand.

At CES 2016 the world saw another progression in the treatment for various forms of sickness from ReliefBand Technologies.

ReliefBand, a FDA cleared wearable device can now treat symptoms and not simply check them.

The patented technology uses programmed pulses with a highly specific waveform, frequency, and intensity to stimulate the median nerve on the underside of the wrist.

Referred to as neuromodulation, this precise activity uses the body’s natural neural pathways to block nausea produced by the stomach.

ReliefBand Motion Sickness

The signals travel to the central nervous system, stimulating between the brain and stomach via the vagus nerve, restoring normal gastric rhythm and relieving nausea.

With no side-effects or safety concerns, that other common RX medications give such as drowsiness, dry mouth, or a potential for an adverse reaction. ReliefBand provides a drug-free solution and the user only needs to slip the device on their wrist and adjust the intensity to suit their needs, feeling better within minutes.

ReliefBand has been clinically proven and prescribed by doctors to treat symptoms of morning sickness, post-operative nausea and sickness caused by chemotherapy for nearly twenty years.

ReliefBand has created an over the counter technology, that is re-usable and affordable for $89.99.

In December 2015, ReliefBand Technologies raised $5 million in venture capital funding in a round led by PathoCapital the specialty healthcare fund headed by former Baxter Healthcare and Ovation Pharmaceuticals CEO, Bill Gantz.

Used for both the relief of morning sickness symptoms and motion sickness.

The all new and improved ReliefBand offers:
  • Improved wearability.
  • Advanced algorithms, better controlling the pulses and effectiveness of the device.
  • Replaceable batteries for on going use and multiple intensity settings.

“With 70% of women experiencing morning sickness during pregnancy and more than 60 million people suffering from motion sickness, ReliefBand is fulfilling a very large unmet need,” said Nick Spring, CEO, ReleifBand technologies.  “With wearable technology becoming widely accepted, the time is now right to bring this clinically proven technology that has been developed over decades to a device that people can buy without a prescription.”

ReliefBand with be available in retail stores i Q! 2016 following its successful Q4 2015 beta test.